Trials / Recruiting
RecruitingNCT06068335
Innate Immunity in Allergic Asthma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Central Florida · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.
Conditions
Timeline
- Start date
- 2021-10-18
- Primary completion
- 2025-06-01
- Completion
- 2025-06-01
- First posted
- 2023-10-05
- Last updated
- 2024-12-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06068335. Inclusion in this directory is not an endorsement.